date:Nov 15, 2018
ement in their glucose regulation and, therefore, did not need to move from oral medication to insulin therapy.
Regarding Type 1 developments, researchers from RMIT University, Australia, are developing early detection technology for Type 1 diabetes that hopes to accurately predict if a child is at risk of the chronic disease. This is significant as there is currently no test for Type 1 diabetes and by the time someone is diagnosed, about 70 percent of their critical insulin-producing cells hav